Marco Hofmann

Title: Marco Hofmann: Innovator in Blood Coagulation Research

Introduction

Marco Hofmann is a notable inventor based in Lahntal-Sterzhausen, Germany. He has made significant contributions to the field of blood coagulation, particularly through his innovative research and patents. His work focuses on improving the treatment of blood coagulation disorders, which can have serious health implications.

Latest Patents

Hofmann holds a patent titled "Modulation of FVIII immunogenicity by truncated VWF." This invention relates to a recombinant polypeptide that comprises a truncated von Willebrand Factor (VWF) capable of binding to blood coagulation Factor VIII (FVIII). The primary aim of this invention is to reduce the immunogenicity of FVIII when co-administered with a blood coagulation Factor VIII protein to subjects suffering from blood coagulation disorders. The patent also encompasses pharmaceutical compositions and kits designed for this purpose. He has 1 patent to his name.

Career Highlights

Marco Hofmann is currently associated with Csl Behring Lengnau AG, where he continues to advance his research in blood coagulation. His work has been instrumental in developing therapies that enhance patient outcomes in coagulation disorders.

Collaborations

Hofmann collaborates with talented professionals in his field, including Anne Verhagen and Sabine Pestel. Their combined expertise contributes to the innovative research environment at Csl Behring Lengnau AG.

Conclusion

Marco Hofmann is a dedicated inventor whose work in blood coagulation research is paving the way for improved treatments. His patent on the modulation of FVIII immunogenicity showcases his commitment to advancing medical science.